Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
The current Johnson & Johnson(JNJ) stock price is $225.46, with a market capitalization of 542.2B. The stock trades at a price-to-earnings (P/E) ratio of 26.05 and offers a dividend yield of 2.3%.
During the trading session on 2026-05-30, Johnson & Johnson(JNJ) shares reached a daily high of $232.00 and a low of $224.59. At a current price of $225.46, the stock is +0.4% higher than the low and still -2.8% under the high.
Trading volume for Johnson & Johnson(JNJ) stock has reached 13.9M, versus its average volume of 8.36M.
Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $251.71 and a low of $149.04.
Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $251.71 and a low of $149.04.
JNJ News
Key Points Recessions are a normal part of the economic cycle and can't be avoided. Investors can prepare for recessions by focusing on resilient sectors like...
The Two Bucket Income Portfolio That Pays $5,000 a Month Plus a Cash Reserve to Survive 2008 Style Drawdowns By Drew Wood Published May 30, 9:18AM EDT Quick R...
...
Analyst ratings
65%
of 26 ratingsMore JNJ News
Johnson & Johnson announced updated results from the Phase 1/1b CHRYSALIS-2 study evaluating intravenous RYBREVANT in combination with LAZCLUZE in patients with...
Johnson & Johnson announced new data from the Phase 3 MajesTEC-9 study demonstrating clinically meaningful and statistically significant improvements in progres...
Johnson & Johnson subsidiaries are integrating Gemtrack radiofrequency tracking technology from MinMaxMedical into DePuy Synthes orthopedic products. The compa...
Johnson & Johnson announced that the U.S. Food and Drug Administration has approved a supplemental Biologics License Application to include evidence in the TREM...
Johnson & Johnson’s JNJ stock has risen 11.8% so far this year. One of the biggest drivers of the increase was J&J’s robust first-quarter 2026 results, as it be...
Using tie-ups has long rewarded J&J, but it sometimes creates awkward situations. Chen Haoming / Zuma Press Johnson & Johnson JNJ 0.48 %increase; green up poin...
Key Points Trump is looking to lower prescription drug prices in ways that could harm the profits of drugmakers in the U.S. Even if that happens, diversified...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.